 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 65 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Glabe C. on PAPER: Cacquevel M. et al., 2012, If it turns out that FAD mutations are generally loss of function, then the phenotype of... 1 May 2012.
|
|
|
 |
|
|
Glabe C. on PAPER: Kayed R. et al., 2013, Recommendation Only. 1 May 2012.
|
|
|
|
|
|
Glabe C. on PAPER: Kaden D. et al., 2012, Recommendation Only. 1 May 2012.
|
|
|
|
|
|
Glabe C. on PAPER: Brotherton TE. et al., 2012, This recent paper by Glass and coworkers reports further insight into the recognition of... 4 Apr 2012.
|
|
|
|
|
|
Glabe C. on PAPER: Winton MJ. et al., 2011, Virginia Lee and coworkers have convincingly demonstrated that the perinuclear, intracellular Aβ... 3 Jun 2011.
|
|
|
|
|
|
Glabe C. on PAPER: Si K. et al., 2010, This is a fascinating example of what appears to be another "functional amyloid." In this , the... 18 Feb 2010.
|
|
|
|
|
|
Glabe C. on PAPER: Fillit H. et al., 2009, Previous studies on small groups of patients have indicated that IVIg treatment may have... 22 Jul 2009.
|
|
|
|
|
|
Glabe C. on PAPER: Britschgi M. et al., 2009, This is certainly a fascinating observation that healthy young individuals have relatively high... 10 Jul 2009.
|
|
|
|
|
|
Glabe C. on PAPER: Dreses-Werringloer U. et al., 2008, Recommendation Only. 9 Jul 2008.
|
|
|
|
|
|
Glabe C. on PAPER: Poling A. et al., 2008, Recommendation Only. 9 Jul 2008.
|
|
|
|
|
|
Glabe C. on PAPER: Green KN. et al., 2008, Recommendation Only. 9 Jul 2008.
|
|
|
|
|
|
Glabe C. on PAPER: Gardberg AS. et al., 2007, Anti-amyloid immunotherapy remains one of the front-line strategies for the development of... 3 Oct 2007.
|
|
|
|
|
|
Glabe C. on NEWS: Enhancing Aβ Fibrillization Boosts Mouse Memory, Alzheimer scientists have long known that amyloid plaques are not always associated with... 17 Aug 2007.
|
|
|
|
|
|
Glabe C. on NEWS: Salzburg: Aβ’s N-terminal Shenanigans, It is quite likely that amino-terminal deletions could also have an impact on the aggregation of... 3 May 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Emadi S. et al., 2007, Recommendation Only. 7 Apr 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Sgourakis NG. et al., 2007, Recommendation Only. 7 Apr 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Bruns CK. et al., 2007, Recommendation Only. 30 Mar 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Volles MJ. et al., 2007, Recommendation Only. 30 Mar 2007.
|
|
|
|
|
|
Glabe C. on PAPER: de Planque MR. et al., 2007, Recommendation Only. 30 Mar 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Periquet M. et al., 2007, Recommendation Only. 30 Mar 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Maloyan A. et al., 2007, Recommendation Only. 30 Mar 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Baumann F. et al., 2007, An interesting insight into the potential function of PrP(C). 30 Mar 2007.
|
|
|
|
|
|
Glabe C. on PAPER: Margittai M. et al., 2006, Parallel, in-register β strand packing is turning out to be a common motif in amyloid fibrils of... 18 Oct 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Zheng J. et al., 2006, More details about how polar and non polar zippers in parallel, in-register amyloids mediate... 18 Oct 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Oakley H. et al., 2006, Recommendation Only. 17 Oct 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Uversky VN. et al., 2006, Amyloids assemble into nanoscale fibrils and oligomers, so nanomedicine may provide insights... 17 Oct 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Redecke L. et al., 2007, Recommendation Only. 17 Oct 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Baglioni S. et al., 2006, Prefibrillar amyloid oligomers are intrinsically toxic in rat brain regardless of their amino... 3 Sep 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Ehrnhoefer DE. et al., 2006, Inhibitor of Htt misfolding and oligomerization reduces polyQ toxicity in vivo. 3 Sep 2006.
|
|
|
|
|
|
Glabe C. on PAPER: Butler D. et al., 2006 Jul-Sep, Recommendation Only. 3 Sep 2006.
|
|
|
|
|
|
|
1 to 30 of 65 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
